X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/vivet-therapeutics-doses-first-patient-in-cohort-2-in-phase-12-gateway-clinical-trial-for-treatment-of-wilson-disease-302109330.html
https://www.prnewswire.com/news-releases/vivet-therapeutics-receives-eur-4-9-million-to-advance-development-of-a-gene-therapy-for-the-treatment-of-cerebrotendinous-xanthomatosis-302049570.html
https://www.globenewswire.com//news-release/2023/10/23/2764603/0/en/Vivet-Therapeutics-Announces-Presentations-at-Upcoming-European-Society-of-Gene-and-Cell-Therapy-ESGCT-2023-Annual-Congress.html
https://www.globenewswire.com/en/news-release/2021/05/10/2226440/0/en/Vivet-Therapeutics-Announces-Multiple-Projects-Update-Including-New-VTX-803-Preclinical-data-To-Be-Presented-At-2021-American-Society-Of-Gene-And-Cell-Therapy-Annual-Meeting.html
https://www.businesswire.com/news/home/20210412005354/en/Mirum-Pharmaceuticals-and-Vivet-Therapeutics-Enter-into-Exclusive-Worldwide-Option-and-License-Agreement-for-Vivet%E2%80%99s-Gene-Therapy-Programs-Targeting-Progressive-Familial-Intrahepatic-Cholestasis
Market Place
Share 
